COG Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma Pediatric CIRB Closed to Accrual. Pts Still Rcving Intervention Available to Open